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Carcinomatous pleuritis in patients with lung cancer is usually found to accompanyfrank malignant pleural effusion and is associated with short-term survival.1However, this condition is sometimes discovered, with or without a small amountof pleural effusion, at thoracotomy in patients with resectable non–small cell lung
cancer. The incidence is reported as 3.2%,2 and in such patients surgical treatment has been
applied in some institutions, with long-term survival in selected cases. We report here the
results of extrapleural pneumonectomy for patients with lung cancer with carcinomatous
pleuritis and discuss surgical treatment for this disease.
Patients and Methods
Between January 1988 and December 1999, a total of 602 patients underwent exploration for
the resection of primary lung cancer at our hospital. Among the patients, 11 (1.7%) under-
went an extrapleural pneumonectomy with lymph node dissection because of carcinomatous
pleuritis. Extrapleural pneumonectomy was performed in patients who had pleural dissemi-
nated tumors with or without a minimal effusion (<300 mL) and an adequate cardiopul-
monary reserve. Patients with massive malignant pleural effusions were excluded from
surgical candidacy. All the patients gave written informed consent for the operation. The
details of the operative procedure were described in our previous case report.3 All patients
underwent excision of the pericardium and complete removal of the hemidiaphragm. The
pericardium and diaphragm were usually reconstructed with synthetic membranes. Data are
reported as means ± SD. Survival was measured from the operation until death or the last date
of follow-up (April 30, 2001), and the data are reported as means and 95% confidence inter-
vals (CI) for the mean. The Kaplan-Meier method was used to calculate actuarial survival.
Results
The demographics of these 11 patients (9 women and 2 men) are shown in Table 1. The mean
age at operation was 50.8 ± 10.9 years (range, 33-70 years). The most common symptoms
were chest pain in 3 patients and cough, dyspnea, and general fatigue in 1 patient each. Five
patients were free of symptoms. Histologic examination, cytologic examination, or both, of
the specimen obtained from the intrapulmonary mass with a fiberoptic bronchoscope or by
percutaneous transthoracic needle biopsy showed adenocarcinoma in 10 patients. Only the
eleventh patient, whose pulmonary nodule was undetectable before the operation, underwent
pleural biopsy, but it was not known whether the lesion originated from lung adenocarcinoma
or malignant pleural mesothelioma. All patients underwent chest computed tomographic scan-
ning to determine clinical staging. Carcinomatous pleuritis was suspected preoperatively in 7
patients; pleural disseminated nodules were observed on computed tomographic scanning in
5 patients, and malignant pleural effusion was detected in 2 patients. However, the remaining
4 patients were given diagnoses of T1, T2, or T3 tumors, and their disease conditions were
found at thoracotomy. Preoperative chemotherapy was performed in only the fourth patient
with N2 disease.
In all patients pathologic examination, including immunohistochemical analysis of the
resected specimen, revealed that the primary tumor was lung adenocarcinoma, and the
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pleural disseminated nodules were compatible with the intrapul-
monary lesion. The operation time was 464.5 ± 51.7 minutes, and
blood loss during the operation was 690.6 ± 300.3 g. The final
pathologic stage was T4 N0 in 4 patients, T4 N1 in 2 patients, and
T4 N2 in 5 patients. All patients survived the operation and were
discharged from the hospital. Complications were intrathoracic
hemorrhage and empyema without bronchopleural fistula in 1
patient each. Postoperative radiotherapy was performed in the
third and tenth patients, and chemotherapy was performed in the
first patient. Follow-up data were complete for all patients. The 5-
year and 10-year survivals of all the patients were 54.5% (95% CI,
25.1%-84.0%) and 36.4% (95% CI, 1.3%-71.5%), respectively.
Among the 6 patients with pathologic N0-1 disease, 4 patients are
alive without disease 20 to 146 months after operation, and the 5-
year survival was 66.7% (95% CI, 28.9%-100%). Of the 5 patients
with N2 disease, all had recurrent disease, and there was only 1
long-term survivor in whom malignant pericardial effusion devel-
oped 6 months after the operation.
Discussion
Non–small cell lung cancer with carcinomatous pleuritis is gener-
ally considered to be a contraindication for surgical treatment and
is associated with a poor outcome.1 However, some surgeons have
continued to perform a resection for selected patients with the dis-
ease.2-4 The Japan Clinical Oncology Group reported that the 5-
year survival of patients undergoing resection for minimal
carcinomatous pleuritis was 22.8%, and being female and having
a clinical N0 stage were significantly good prognostic factors.2
Extrapleural pneumonectomy has been used by thoracic sur-
geons in the treatment of diffuse malignant pleural mesothelioma,
as well as other pleural diseases, such as tuberculus empyema. The
efficacy of this procedure has been suggested in managing patients
with malignant pleural mesothelioma localized in the hemithorax.5
In this study our patients had lung adenocarcinoma and pleural
disseminated nodules with or without a small amount of malignant
effusion, which was compatible with minimal disease described
by the Japan Clinical Oncology Group2 and might be a localized
disease in the hemithorax. Extrapleural pneumonectomy with
lymph node dissection was performed safely in all patients and
resulted in a good long-term survival, especially in female patients
without pathologic N2 disease. Our results indicate that carefully
selected patients with carcinomatous pleuritis may be candidates
for extrapleural pneumonectomy for cure. Nevertheless, the ulti-
mate value of this surgical treatment should be ascertained in a
prospective study with a large number of patients because our
results may have been affected by the nature of the tumors, such
as the slow-growing tumor noted in the third patient.
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TABLE 1. Patients with lung cancer who underwent an extrapleural pneumonectomy for carcinomatous pleuritis
Stage Operation Survival after operation (mo)
Patient No. (age [y], sex) Clinical Pathologic Time (min) Blood loss (g) Recurrence Disease free Overall
1 (44, F) T2 N0 T4 N1 430 1300 — 149 149; alive without disease
2 (41, F) T1 N0 T4 N0 510 323 — 87 87; alive without disease
3 (58, M) T4 N2 T4 N2 495 980 Pericardial effusion 6 79; died of disease
4 (49, F) T4 N2 T4 N2 520 600 Supraclavicular 14 25; alive with disease
lymph nodes
5 (62, F) T2 N0 T4 N0 470 700 Unknown Unknown 20; died of disease
6 (49, F) T4 N0 T4 N0 464 297 — 20 20; alive without disease
7 (49, F) T4 N0 T4 N0 361 452 — 20 20; alive without disease
8 (70, F) T4 N0 T4 N2 407 539 Skin 7 19; died of disease
9 (33, M) T4 N0 T4 N2 535 896 Bone 4 11; died of disease
10 (61, F) T3 N2 T4 N1 473 660 — 6 6; died of other cause
11 (43, F) T4 N0 T4 N2 445 850 Unknown Unknown 6; died of disease
